<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Ecological genetics</journal-id><journal-title-group><journal-title xml:lang="en">Ecological genetics</journal-title><trans-title-group xml:lang="ru"><trans-title>Экологическая генетика</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1811-0932</issn><issn publication-format="electronic">2411-9202</issn><publisher><publisher-name xml:lang="en">Eco-Vector</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">16327</article-id><article-id pub-id-type="doi">10.17816/ecogen16327</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Human ecological genetics</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Экологическая генетика человека</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Human diseases associated with NTE gene</article-title><trans-title-group xml:lang="ru"><trans-title>Заболевания человека, ассоциированные с геном NTE</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Melentev</surname><given-names>Pavel A.</given-names></name><name xml:lang="ru"><surname>Мелентьев</surname><given-names>Павел Алексеевич</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>PhD student. Laboratory of Experimental and Applied Genetics</p></bio><bio xml:lang="ru"><p>аспирант, лаборатория экспериментальной и прикладной генетики</p></bio><email>melentev_pa@pnpi.nrcki.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Agranovich</surname><given-names>Olga E.</given-names></name><name xml:lang="ru"><surname>Агранович</surname><given-names>Ольга Евгеньевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Medicine, Head of Artrogriposis Department, Orthopedic Trauma Surgeon</p></bio><bio xml:lang="ru"><p>д-р мед. наук, руководитель отделения артрогрипоза, врач травматолог-ортопед</p></bio><email>olga_agranovich@yahoo.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Sarantseva</surname><given-names>Svetlana V.</given-names></name><name xml:lang="ru"><surname>Саранцева</surname><given-names>Светлана Владимировна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Doctor of Science, Head of Laboratory of Experimental and Applied Genetics, Deputy Director for Science. Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC</p></bio><bio xml:lang="ru"><p>д-р биол. наук, заведующая лабораторией экспериментальной и прикладной генетики, заместитель директора по научной работе</p></bio><email>sarantseva_sv@pnpi.nrcki.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Petersburg Nuclear Physics Institute named by B.P. Konstantinov of NRC “Kurchatov Institute”</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное учреждение «Петербургский институт ядерной физики им. Б.П. Константинова» Национального исследовательского центра «Курчатовский институт»</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Turner Scientific Research Institute for Children’s Orthopedics</institution></aff><aff><institution xml:lang="ru">Федеральное государственное бюджетное учреждение «Национальный медицинский исследовательский центр детской травматологии и ортопедии им. Г.И. Турнера» Министерства здравоохранения Российской Федерации</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2020-04-14" publication-format="electronic"><day>14</day><month>04</month><year>2020</year></pub-date><pub-date date-type="pub" iso-8601-date="2020-07-08" publication-format="electronic"><day>08</day><month>07</month><year>2020</year></pub-date><volume>18</volume><issue>2</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>229</fpage><lpage>242</lpage><history><date date-type="received" iso-8601-date="2019-10-04"><day>04</day><month>10</month><year>2019</year></date><date date-type="accepted" iso-8601-date="2020-03-06"><day>06</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2020, Melentev P.A., Agranovich O.E., Sarantseva S.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2020, Мелентьев П.А., Агранович О.Е., Саранцева С.В.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder xml:lang="en">Melentev P.A., Agranovich O.E., Sarantseva S.V.</copyright-holder><copyright-holder xml:lang="ru">Мелентьев П.А., Агранович О.Е., Саранцева С.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2021-05-14"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">http://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journals.eco-vector.com/ecolgenet/article/view/16327">https://journals.eco-vector.com/ecolgenet/article/view/16327</self-uri><abstract xml:lang="en"><p>Evolutionary conserved <italic>NTE</italic> gene is important for survival and functioning of nervous system cells, its dysfunction leads to various pathologies. Here we describe characteristics of different disorders induced by NTE protein activity inhibition (OPIDN) or by <italic>NTE</italic> gene mutations: hereditary spastic paraplegia (SPG39), Boucher – Neuhaüser, Gordon Holmes, Laurence – Moon, Oliver – McFarlane syndromes, Leber congenital amaurosis, pure cerebellar ataxia. Current review summarises accumulated data about clinical features of <italic>NTE</italic> associated diseases, presenting them in a historical way of biomedical studies, and observes molecular and genetic causes of these disorders.</p></abstract><trans-abstract xml:lang="ru"><p>Эволюционно консервативный ген <italic>NTE</italic> играет важную роль в поддержании жизнеспособности и функционирования клеток нервной системы, а нарушение его работы приводит к различным патологиям. В работе рассмотрены характерные черты различных болезней, как вызванных ингибированием активности белка NTE (OPIDN), так и обусловленных мутациями в гене <italic>NTE</italic>: наследственная спастическая параплегия (форма SPG39), синдромы Boucher – Neuhaüser, Gordon Holmes, Laurence – Moon, Oliver – McFarlane, врожденный амавроз Лебера, чистая мозжечковая атаксия. Обзор обобщает накопленные данные о клинической картине заболеваний человека, ассоциированных с геном <italic>NTE</italic>, представляя их в историческом аспекте медико-биологических исследований, и рассматривает молекулярно-генетические закономерности этиологии этих болезней.</p></trans-abstract><kwd-group xml:lang="en"><kwd>NTE</kwd><kwd>PNPLA6</kwd><kwd>hSWS</kwd><kwd>neurodegeneration</kwd><kwd>nervous system disorders</kwd><kwd>hereditary diseases</kwd><kwd>spastic paraplegia</kwd><kwd>ataxia</kwd><kwd>organophosphates</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>NTE</kwd><kwd>PNPLA6</kwd><kwd>hSWS</kwd><kwd>нейродегенерация</kwd><kwd>болезни нервной системы</kwd><kwd>наследственные заболевания</kwd><kwd>спастическая параплегия</kwd><kwd>атаксия</kwd><kwd>органофосфаты</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Государственное задание НИЦ</institution></institution-wrap><institution-wrap><institution xml:lang="en">Russian government</institution></institution-wrap></funding-source></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Kienesberger P, Oberer M, Lass A, Zechner R. Mammalian patatin domain containing proteins: a family with diverse lipolytic activities involved in multiple biological functions. J Lipid Res. 2008;50(Suppl):S63-S68. https://doi.org/ 10.1194/jlr.r800082-jlr200.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Glynn P. Neural development and neurodegeneration: two faces of Neuropathy Target Esterase. Prog Neurobiol. 2000;61(1):61-74. https://doi.org/10.1016/s0301-0082(99)00043-x.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Moser M, Stempfl T, Li Y, et al. Cloning and expression of the murine sws/NTE gene. Mech Dev. 2000;90(2):279-282. https://doi.org/10.1016/s0925-4773(99)00239-7.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Moser M, Li Y, Vaupel K, et al. Placental failure and impaired vasculogenesis result in embryonic lethality for neuropathy target esterase-deficient mice. Mol Cell Biol. 2004;24(4):1667-1679. https://doi.org/10.1128/mcb.24.4.1667-1679.2004.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Akassoglou K, Malester B, Xu J, et al. Brain-specific deletion of neuropathy target esterase/swiss cheese results in neurodegeneration. Proc Natl Acad Sci U S A. 2004;101(14):5075-5080. https://doi.org/10.1073/pnas.0401030101.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Smith M, Elvove E. Pharmacological and chemical studies of the cause of so-called ginger paralysis: a preliminary report. Public Health Reports (1896-1970). 1930;45(30):1703. https://doi.org/10.2307/4579730.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Aring C. The systemic nervous affinity of triorthocresyl phosphate (Jamaica ginger palsy). Brain. 1942;65(1):34-47. https://doi.org/10.1093/brain/65.1.34.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Johnson M. Organophosphates and delayed neuropathy – is NTE alive and well? Toxicol Appl Pharmacol. 1990;102(3):385-399. https://doi.org/10.1016/0041-008x(90)90036-t.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Hou W, Long D, Wang H, et al. The homeostasis of phosphatidylcholine and lysophosphatidylcholine was not disrupted during tri-o-cresyl phosphate-induced delayed neurotoxicity in hens. Toxicology. 2008;252(1-3):56-63. https://doi.org/10.1016/j.tox.2008.07.061.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Johnson M, Jacobsen D, Meredith T, et al. Evaluation of antidotes for poisoning by organophosphorus pesticides. Emerg Med Australas. 2000;12(1):22-37. https://doi.org/10.1046/j.1442-2026.2000.00087.x.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Salvi R. Neuropsychiatric Evaluation in subjects chronically exposed to organophosphate pesticides. Toxicol Sci. 2003;72(2):267-271. https://doi.org/10.1093/toxsci/kfg034.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Johnson M. The delayed neurotoxic effect of some organophosphorus compounds. Identification of the phosphorylation site as an esterase. Biochem J. 1969;114(4):711-717. https://doi.org/10.1042/bj1140711.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Johnson M. A phosphorylation site in brain and the delayed neurotoxic effect of some organophosphorus compounds. Biochem J. 1969;111(4): 487-495. https://doi.org/10.1042/bj1110487.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Craig P, Barth M. Evaluation of the hazards of industrial exposure to tricresyl phosphate: a review and interpretation of the literature. J Toxicol Environ Health B Crit Rev. 1999;2(4):281-300. https://doi.org/10.1080/109374099281142.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Emerick GL, Deoliveira GH, Santos ACD, Ehrich M. Mechanisms for consideration for intervention in the development of organophosphorus-induced delayed neuropathy. Chem Biol Interact. 2012;199(3):177-184. https://doi.org/10.1016/j.cbi.2012.07.002.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Johnson MK. Improved assay of neurotoxic esterase for screening organophosphates for delayed neurotoxicity potential. Arch Toxicol. 1977;37(2): 113-115. https://doi.org/10.1007/bf00293860.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Cavanagh JB. The toxic effects of tri-ortho-cresyl phosphate on the nervous system: an experimental study in hens. J Neurol Neurosurg Psychiatry. 1954;17(3):163-172. https://doi.org/10.1136/jnnp.17.3.163.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Dudek BR, Richardson RJ. Evidence for the existence of neurotoxic esterase in neural and lymphatic tissue of the adult hen. Biochem Pharmacol. 1982;31(6):1117-1121. https://doi.org/ 10.1016/0006-2952(82)90351-3.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Bertoncin D, Russolo A, Caroldi S, Lotti M. Neuropathy target esterase in human lymphocytes. Archives of Environmental Health: An International Journal. 1985;40(3):139-144. https://doi.org/10.1080/00039896.1985.10545905.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Makhaeva GF, Rudakova EV, Sigolaeva LV, et al. Neuropathy target esterase in mouse whole blood as a biomarker of exposure to neuropathic organophosphorus compounds. J Appl Toxicol. 2016;36(11):1468-1475. https://doi.org/10.1002/jat.3305.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Emerick GL, Peccinini RG, Oliveira GHD. Organophosphorus-induced delayed neuropathy: A simple and efficient therapeutic strategy. Toxicol Lett. 2010;192(2):238-244. https://doi.org/10.1016/j.toxlet.2009.10.032.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Jortner BS. Preparation and analysis of the peripheral nervous system. Toxicol Pathol. 2010;39(1): 66-72. https://doi.org/10.1177/0192623310387618.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Gupta RP, Abou-Donia MB. Tau proteins-enhanced Ca2/calmodulin (CaM)-dependent phosphorylation by the brain supernatant of diisopropyl phosphorofluoridate (DFP)-treated hen: tau mutants indicate phosphorylation of more amino acids in tau by CaM kinase II. Brain Res. 1998;813(1):32-43. https://doi.org/10.1016/s0006-8993(98)00988-3.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Faber I, Pereira ER, Martinez AR, et al. Hereditary spastic paraplegia from 1880 to 2017: an historical review. Arq Neuropsiquiatr. 2017;75(11):813-818. https://doi.org/10.1590/0004-282X20170160.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>de Souza PV, de Rezende Pinto WB, de Rezende Batistella GN, et al. Hereditary spastic paraplegia: clinical and genetic hallmarks. The Cerebellum. 2017;16(2):525-551. https://doi.org/10.1007/s12311-016-0803-z.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Seeligmüller A. Sklerose der seitenstrange des ruckenmards bei vier kindern derselben gamilie. Dtsch Med Wochenshnr. 1876;2:185-186.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Strümpell A. Beiträge zur Pathologie des Rückenmarks. Eur Arch Psychiatry Clin Neurosci. 1880;10(3):676-717. https://doi.org/10.1007/bf02054821.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Rhein JH. Family spastic paralysis. The Journal of Nervous and Mental Disease. 1916;44(2): 115-144. https://doi.org/10.1097/00005053-191609000-00004.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Garland HG, Astley CE. Hereditary spastic paraplegia with amyotrophy and pes cavus. J Neurol Neurosurg Psychiatry Res. 1950;13(2):130-133. https://doi.org/10.1136/jnnp.13.2.130.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bickerstaff ER. Hereditary spastic paraplegia. J Neurol Neurosurg Psychiatry Res. 1950;13(2): 134-145. https://doi.org/10.1136/jnnp.13.2.134.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Strümpell A. Die primäre Seitenstrangsklerose (spastische Spinalparalyse). Deutsche Zeitschrift für Nervenheilkunde. 1904;27(3-4):291-339. https://doi.org/10.1007/bf01667115.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Deluca GC, Ebers GC, Esiri MM. The extent of axonal loss in the long tracts in hereditary spastic paraplegia. Neuropathol Appl Neurobiol. 2004;30(6):576-584. https://doi.org/10.1111/j.1365-2990.2004.00587.x.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Schut JW, Haymaker W. Hereditary ataxia: a pathologic study of five cases of common ancestry. J Neuropathol Clin Neurol. 1951;1(3):183-213.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Behan WM, Maia M. Strumpells familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry Res. 1974;37(1):8-20. https://doi.org/10.1136/jnnp.37.1.8.</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Greenfield JG, Aring CD. The spino-cerebellar degenerations. Edited by Charles D. Aring. Blackwell Scientific Publications; 1954.</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Rainier S, Bui M, Mark E, et al. Neuropathy target esterase gene mutations cause motor neuron disease. Am J Hum Genet. 2008;82(3):780-785. https://doi.org/10.1016/j.ajhg.2007.12.018.</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Rainier S, Albers JW, Dyck PJ, et al. Motor neuron disease due to neuropathy target esterase gene mutation: clinical features of the index families. Muscle Nerve. 2010;43(1):19-25. https://doi.org/10.1002/mus.21777.</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Synofzik M, Gonzalez MA, Lourenco CM, et al. PNPLA6 mutations cause Boucher – Neuhäuser and Gordon Holmes syndromes as part of a broad neurodegenerative spectrum. Brain. 2013;137(1):69-77. https://doi.org/10.1093/brain/awt326.</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Tarnutzer AA, Gerth-Kahlert C, Timmann D, et al. Boucher – Neuhäuser syndrome: cerebellar degeneration, chorioretinal dystrophy and hypogonadotropic hypogonadism: two novel cases and a review of 40 cases from the literature. J Neurol. 2014;262(1):194-202. https://doi.org/10.1007/s00415-014-7555-9.</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Teive HA, Camargo CH, Sato MT, et al. Different cerebellar ataxia phenotypes associated with mutations of the PNPLA6 gene in Brazilian patients with recessive ataxias. The Cerebellum. 2017;17(3):380-385. https://doi.org/10.1007/s12311-017-0909-y.</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Boucher RJ, Gibberd FB. Familial ataxia, hypogonadism and retinal degeneration. Acta Neurol Scand. 2009;45(4):507-510. https://doi.org/10.1111/j.1600-0404.1969.tb01261.x.</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Neuhäuser G, Opitz JM. Autosomal recessive syndrome of cerebellar ataxia and hypogonadotropic hypogonadism. Clin Genet. 2008;7(5):426-434. https://doi.org/10.1111/j.1399-0004.1975.tb00353.x.</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Limber ER, Bresnick GH, Lebovitz RM, et al. Spinocerebellar ataxia, hypogonadotropic hypogonadism, and choroidal dystrophy (Boucher – Neuhäuser syndrome. Am J Med Genet. 1989;33(3):409-414. https://doi.org/10.1002/ajmg.1320330325.</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Rump R, Hamel BC, Pinckers AJ, Dop PAV. Two sibs with chorioretinal dystrophy, hypogonadotrophic hypogonadism, and cerebellar ataxia: Boucher – Neuhäuser syndrome. J Med Genet. 1997;34(9):767-771. https://doi.org/10.1136/jmg.34.9.767.</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Sak JJ, Grzybowski A, Baj J. Sir Gordon Morgan Holmes (1876–1965): one of the founders of modern neurology. Neurol Sci. 2017;39(1): 169-171. https://doi.org/10.1007/s10072-017-3180-6.</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Holmes G. A form of familial degeneration of the cerebellum. Brain. 1908;30(4):466-489. https://doi.org/10.1093/brain/30.4.466.</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Topaloglu AK, Lomniczi A, Kretzschmar D, et al. Loss-of-function mutations in PNPLA6 encoding neuropathy target esterase underlie pubertal failure and neurological deficits in Gordon Holmes syndrome. J Clin Endocrinol Metab. 2014;99(10). https://doi.org/10.1210/jc.2014-1836.</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Hufnagel RB, Arno G, Hein ND, et al. Neuropathy target esterase impairments cause Oliver – McFarlane and Laurence – Moon syndromes. J Med Genet. 2015;52(2):85-94. https://doi.org/10.1136/jmedgenet-2014-102856.</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Kmoch S, Majewski J, Ramamurthy V, et al. Mutations in PNPLA6 are linked to photoreceptor degeneration and various forms of childhood blindness. Nat Commun. 2015;6(1). https://doi.org/10.1038/ncomms6614.</mixed-citation></ref><ref id="B50"><label>50.</label><mixed-citation>Oliver GL, McFarlane DC. Congenital trichomegaly: with associated pigmentary degeneration of the retina, dwarfism, and mental retardation. Arch Ophthalmol. 1965;74(2):169-171. https://doi.org/10.1001/archopht.1965.00970040171008.</mixed-citation></ref><ref id="B51"><label>51.</label><mixed-citation>Patton M, Harding A, Baraitser M. Congenital trichomegaly, pigmentary retinal degeneration, and short stature. Am J Ophthalmol. 1986;101(4):490-491. https://doi.org/10.1016/0002-9394(86)90656-2.</mixed-citation></ref><ref id="B52"><label>52.</label><mixed-citation>Laurence JZ. Four cases of retinitis pigmentosa occurring in the same family, and accompanied by general imperfections of development. Ophthalmol Rev. 1866;2:32-41.</mixed-citation></ref><ref id="B53"><label>53.</label><mixed-citation>Laurence JZ, Moon RC. Four cases of «retinitis pigmentosa» occurring in the same family, and accompanied by general imperfections of development. Obes Res. 1995;3(4):400-403. https://doi.org/10.1002/j.1550-8528.1995.tb00166.x.</mixed-citation></ref><ref id="B54"><label>54.</label><mixed-citation>Bowen P. The Laurence-Moon syndrome. Association with hypogonadotrophic hypogonadism and sex-chromosome aneuploidy. Arch Intern Med. 1965;116(4):598-604. https://doi.org/10.1001/archinte.116.4.598.</mixed-citation></ref><ref id="B55"><label>55.</label><mixed-citation>Kumaran N, Moore AT, Weleber RG, Michaelides M. Leber congenital amaurosis/early-onset severe retinal dystrophy: clinical features, molecular genetics and therapeutic interventions. Br J Ophthalmol. 2017;101(9):1147-1154. https://doi.org/10.1136/bjophthalmol-2016-309975.</mixed-citation></ref><ref id="B56"><label>56.</label><mixed-citation>Wiethoff S, Bettencourt C, Paudel R, et al. Pure Cerebellar Ataxia with Homozygous Mutations in the PNPLA6 Gene. The Cerebellum. 2016;16(1):262-267. https://doi.org/10.1007/s12311-016-0769-x.</mixed-citation></ref><ref id="B57"><label>57.</label><mixed-citation>Synofzik M, Schüle R. Overcoming the divide between ataxias and spastic paraplegias: Shared phenotypes, genes, and pathways. Mov Disord. 2017;32(3):332-345. https://doi.org/10.1002/mds.26944.</mixed-citation></ref></ref-list></back></article>
